TY - JOUR
T1 - Gamma Knife Radiosurgery for Uveal Melanoma
T2 - Our Experience and Thematic Review
AU - Phalak, Manoj
AU - Lomi, Neiwete
AU - Ganeshkumar, Akshay
AU - Singh, Simranjeet
AU - Garg, Kanwaljeet
AU - Natanasabhapathi, Gopishankar
AU - Singh, Manmohan
AU - Kumar, Rajinder
AU - Sharad Kale, Shashank
N1 - Publisher Copyright:
© 2023 Neurology India, Neurological Society of India | Published by Wolters Kluwer - Medknow.
PY - 2023/3
Y1 - 2023/3
N2 - Background: Various therapies ranging from plaque brachytherapy to enucleation have been applied in uveal melanomas (UM). A gamma knife (GK) is the gold standard modality for head and neck radiation therapy with enhanced precision owing to the paucity of moving parts. The literature on GK usage in UM is rich with the methodology and nuances of GK applications undergoing constant change. Objectives: This article reports on the authors’ experience in using GK for tackling UM followed by a thematic review of the evolution of GK therapy for UM. Materials and Methods: Clinical and radiological data of patients with UM treated with GK at the All India Institute of Medical Sciences, New Delhi, from March 2019 to August 2020 was analyzed. A systematic search for comparative studies and case series evaluating GK usage in UM was performed. Results: Seven UM patients underwent GK, with the median dose being 28 Gy at 50%. All patients underwent clinical follow‑up and 3 patients had a radiological follow‑up. Six (85.7%) eyes were preserved at follow‑up, and 1 (14.28%) patient developed radiation‑induced cataract. There was a reduction in tumor volume in all patients with radiological follow‑up with the minimum being a 33.06% reduction in size compared to the presenting volume and the maximum being the complete disappearance of tumor at follow‑up. A total of 36 articles presenting various facets of GK usage in UM have been thematically reviewed. Conclusion: GK can be a viable and effective eye‑preserving option for UM with catastrophic side effects becoming rare owing to progressive reduction in radiation dose.
AB - Background: Various therapies ranging from plaque brachytherapy to enucleation have been applied in uveal melanomas (UM). A gamma knife (GK) is the gold standard modality for head and neck radiation therapy with enhanced precision owing to the paucity of moving parts. The literature on GK usage in UM is rich with the methodology and nuances of GK applications undergoing constant change. Objectives: This article reports on the authors’ experience in using GK for tackling UM followed by a thematic review of the evolution of GK therapy for UM. Materials and Methods: Clinical and radiological data of patients with UM treated with GK at the All India Institute of Medical Sciences, New Delhi, from March 2019 to August 2020 was analyzed. A systematic search for comparative studies and case series evaluating GK usage in UM was performed. Results: Seven UM patients underwent GK, with the median dose being 28 Gy at 50%. All patients underwent clinical follow‑up and 3 patients had a radiological follow‑up. Six (85.7%) eyes were preserved at follow‑up, and 1 (14.28%) patient developed radiation‑induced cataract. There was a reduction in tumor volume in all patients with radiological follow‑up with the minimum being a 33.06% reduction in size compared to the presenting volume and the maximum being the complete disappearance of tumor at follow‑up. A total of 36 articles presenting various facets of GK usage in UM have been thematically reviewed. Conclusion: GK can be a viable and effective eye‑preserving option for UM with catastrophic side effects becoming rare owing to progressive reduction in radiation dose.
KW - Choroidal melanoma
KW - gamma knife
KW - stereotactic radiosurgery
KW - uveal melanoma
KW - Melanoma/radiotherapy
KW - Follow-Up Studies
KW - Humans
KW - Treatment Outcome
KW - Retrospective Studies
KW - Radiosurgery/methods
KW - Uveal Neoplasms/radiotherapy
KW - India
UR - http://www.scopus.com/inward/record.url?scp=85151882905&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85151882905&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/b7711f1b-49ac-3db6-bb25-77c06777f972/
U2 - 10.4103/0028-3886.373650
DO - 10.4103/0028-3886.373650
M3 - Review article
C2 - 37026349
AN - SCOPUS:85151882905
SN - 0028-3886
VL - 71
SP - 168
EP - 173
JO - Neurology India
JF - Neurology India
IS - 7
ER -